Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Relay Therapeutics Inc (NASDAQ: RLAY) closed the day trading at $4.34 up 4.33% from the previous closing price of $4.16. In other words, the price has increased by $4.33 from its previous closing price. On the day, 1.99 million shares were traded. RLAY stock price reached its highest trading level at $4.365 during the session, while it also had its lowest trading level at $4.12.
Ratios:
For a better understanding of RLAY, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 18.42 and its Current Ratio is at 18.42. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on September 10, 2024, Upgraded its rating to Buy and sets its target price to $16 from $10.60 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 16 ’24 when Patel Sanjiv sold 100,000 shares for $5.00 per share. The transaction valued at 500,000 led to the insider holds 574,548 shares of the business.
THE PATEL FAMILY IRREVOCABLE U bought 100,000 shares of RLAY for $500,000 on Dec 16 ’24. On Oct 28 ’24, another insider, Rahmer Peter, who serves as the insider of the company, sold 1,621 shares for $6.06 each. As a result, the insider received 9,823 and left with 390,063 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 726442304 and an Enterprise Value of -93480896. For the stock, the TTM Price-to-Sale (P/S) ratio is 70.87 while its Price-to-Book (P/B) ratio in mrq is 0.86. Its current Enterprise Value per Revenue stands at -9.342 whereas that against EBITDA is 0.24.
Stock Price History:
Over the past 52 weeks, RLAY has reached a high of $12.14, while it has fallen to a 52-week low of $4.11. The 50-Day Moving Average of the stock is -19.17%, while the 200-Day Moving Average is calculated to be -35.72%.
Shares Statistics:
Over the past 3-months, RLAY traded about 1.94M shares per day on average, while over the past 10 days, RLAY traded about 3363990 shares per day. A total of 166.89M shares are outstanding, with a floating share count of 123.36M. Insiders hold about 26.30% of the company’s shares, while institutions hold 73.16% stake in the company. Shares short for RLAY as of 1732838400 were 11930533 with a Short Ratio of 6.14, compared to 1730332800 on 12043516. Therefore, it implies a Short% of Shares Outstanding of 11930533 and a Short% of Float of 8.649999999999999.
